152 related articles for article (PubMed ID: 18066596)
1. Synergistic antitumor effect of CXCL10 with hyperthermia.
Chen P; Yang LL; Yang HS; Wang YS; Li G; Wu Y; Fang F; Liu K; Li J; Zhao X; Hu HZ; Wei YQ
J Cancer Res Clin Oncol; 2008 Jun; 134(6):679-87. PubMed ID: 18066596
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.
Li G; Tian L; Hou JM; Ding ZY; He QM; Feng P; Wen YJ; Xiao F; Yao B; Zhang R; Peng F; Jiang Y; Luo F; Zhao X; Zhang L; Zhou Q; Wei YQ
Clin Cancer Res; 2005 Jun; 11(11):4217-24. PubMed ID: 15930360
[TBL] [Abstract][Full Text] [Related]
3. Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26.
Nie W; Ma XL; Sang YX; Li YL; Gao X; Xu GC; Shen GB; Shi HS; Liu XX; Wang FT; Wei YQ
Clin Exp Med; 2014 May; 14(2):203-13. PubMed ID: 23263406
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
[TBL] [Abstract][Full Text] [Related]
5. CXC-chemokine-ligand-10 gene therapy efficiently inhibits the growth of cervical carcinoma on the basis of its anti-angiogenic and antiviral activity.
Wang LL; Chen P; Luo S; Li J; Liu K; Hu HZ; Wei YQ
Biotechnol Appl Biochem; 2009 Jul; 53(3):209-16. PubMed ID: 19257857
[TBL] [Abstract][Full Text] [Related]
6. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effect of recombinant adeno-associated virus-mediated pigment epithelium-derived factor with hyperthermia on solid tumor.
Wu Q; He S; Wei X; Shao B; Luo S; Guo F; Zhang H; Wang Y; Gong C; Yang L
Hum Gene Ther; 2014 Sep; 25(9):811-23. PubMed ID: 25003563
[TBL] [Abstract][Full Text] [Related]
8. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
Lu XL; Jiang XB; Liu RE; Zhang SM
Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model.
Mei K; Wang L; Tian L; Yu J; Zhang Z; Wei Y
J Exp Clin Cancer Res; 2008 Nov; 27(1):63. PubMed ID: 18983688
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].
Mei K; Tian L; Wei YQ; Li J; Wen YJ; Kan B; Deng HX
Ai Zheng; 2005 Apr; 24(4):397-402. PubMed ID: 15820059
[TBL] [Abstract][Full Text] [Related]
11. Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin.
Wang R; Zhang XW; Wang GQ; Chen XC; Tian L; Yang HS; Hu M; Peng F; Yang JL; He QM; Zhang W; Jiang Y; Deng HX; Wen YJ; Li J; Zhao X; Wei YQ
Cancer Gene Ther; 2006 Oct; 13(10):940-7. PubMed ID: 16799469
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic effects of human recombinant TNF and hyperthermia on in vitro cytotoxicity and artificial metastases].
Umeno H; Watanabe N; Sone H; Neda H; Yamauchi N; Maeda M; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1286-91. PubMed ID: 3579327
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors.
Huang H; Liu Y; Xiang J
Cell Immunol; 2002; 217(1-2):12-22. PubMed ID: 12425997
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
16. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
[TBL] [Abstract][Full Text] [Related]
17. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
18. Whole-body hyperthermia maintains the secondary immune response of specific antitumour immune T cells.
Ozawa H; Matsuda T; Iwaguchi T
Int J Hyperthermia; 1991; 7(1):125-30. PubMed ID: 2051068
[TBL] [Abstract][Full Text] [Related]
19. Combination of Caspy2 and IP-10 gene therapy significantly improves therapeutic efficacy against murine malignant neoplasm growth and metastasis.
Zhang N; Yang Y; Cheng L; Zhang XM; Zhang S; Wang W; Liu SY; Wang SY; Wang RB; Xu WJ; Dai L; Yan N; Fan P; Dai LX; Tian HW; Liu L; Deng HX
Hum Gene Ther; 2012 Aug; 23(8):837-46. PubMed ID: 22548488
[TBL] [Abstract][Full Text] [Related]
20. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
